Skip to content

Study and analysis of a new therapeutic technique for implementation in adults

Informational Quantum Homeostasis: implementation and methodological analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-47m37gx
Enrollment
Unknown
Registered
2020-12-15
Start date
2018-07-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tobacco use disorder

Interventions

Experimental group (1): 25 adults who underwent the treatment of Informational Quantum Homeostasis. Control group (2): 25 adults who did not receive treatment with Informational Quantum Homeostasis. I
E02.190

Sponsors

Centro Internacional de Terapia, Avaliação e Pesquisa em Homeostase Quântica Informacional (CTHQI)
Lead Sponsor

Eligibility

Age
45 Years to 60 Years

Inclusion criteria

Inclusion criteria: Adults in the 45 to 60 age group under the following conditions: never having been treated with the HQI technique; never having taken a course on HQI; be resident in the metropolitan region of Campinas, Sorocaba, Jundiaí and in the city of São Paulo, with availability to move to Campinas once a month for individual assistance. And individuals who understood and agreed to the search terms and signed a free and informed consent form.

Exclusion criteria

Exclusion criteria: The study excluded: adults with severe cognitive impairment suggestive of dementia; those who were bedridden, temporarily or permanently; patients with severe stroke sequelae, with localized loss of strength; patients with Parkinson's disease in severe or unstable stages; adults who were terminally ill with any disease; those undergoing treatment for cancer, except for skin; those who had visual or hearing impairments; people who had seizure problems. Ineligible adults were also considered unable to attend the place of care, either due to any of the above criteria or due to access difficulties.

Design outcomes

Primary

MeasureTime frame
Observe a significant decrease in the health problems presented by the participants, verified by the Cochran test, followed by the McNemar test. To compare the numerical variables between pre and post-intervention, in the total sample and in each group, the Friedman test for related samples was used, followed by the Wilcoxon test. The level of significance adopted for finding a variation between groups was 5%.;Observar diminuição significativa nos problemas emocionais apresentados pelos participantes, verificado pelo teste de Cochran, seguido do teste de McNemar. Para comparar as variáveis numéricas entre pré e pós-intervenção, na amostra total e em cada grupo foi usado o teste de Friedman para amostras relacionadas, seguido do teste de Wilcoxon. O nível de significância adotado para constatação de uma variação entre os grupos foi de 5%. ;Observe a significant increase in adherence to physical activity by the participants, verified by the Cochran test, followed by the McNemar test. To compare the numerical variables between pre and post-intervention, in the total sample and in each group, the Friedman test for related samples was used, followed by the Wilcoxon test. The level of significance adopted for finding a variation between groups was 5%.

Secondary

MeasureTime frame
Secondary outcomes are not expected.

Countries

Brazil

Contacts

Public ContactWanda Patrocinio
wanda@gerovida.com.br+55-19-997790989

Outcome results

None listed

Source: REBEC (via WHO ICTRP)